www.fdanews.com/articles/115115-vertex-to-buy-hepatitis-c-drug-developer

Vertex to Buy Hepatitis C Drug Developer

March 4, 2009

Vertex Pharmaceuticals is adding two new drugs to its hepatitis C pipeline with the acquisition of ViroChem, a privately held Canadian drugmaker, the company announced.
TheStreet.com